TRIST

Welcome to the Brand page for “TRIST”, which is offered here for Gene therapy and prophylaxis products, gene delivery pharmaceuticals; pharmaceuticals for the delivery of genes to muscle cells, all for medical purposes; vaccines, enzymes, and enzyme preparations for the treatment of cancer; hypoxia response pharmaceutical substances and preparations, viral and retroviral vectors, viral and retroviral vector manufacturing preparations for the treatment of cancer; pharmaceutical and biochemical preparations for the treatment of cancer;chemicals for use in industry and science, enzymes for scientific and research purposes; chemical products for in-vitro use in laboratories and for analysis, enzymes and chemicals for use in gene delivery technology for laboratory and research use; micro-organisms for laboratory and research use, cell cultures for laboratory and research use, plasmids and cultures of micro organisms for laboratory and research use, deoxyribonucleic acid sequences for laboratory and research use, cloning vehicles, chemical preparations for scientific purposes for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof for laboratory and research use, all for in-vivo use;instruments and apparatus for the administration of gene therapy vaccines and prophylaxis preparations and substances and pre-filled vials, syringes and injectors containing pharmaceuticals for the treatment of cancer sold as a unit;scientific and medical research and development; genetic engineering services for scientific purposes; biotechnology services, research and development in the field of biotechnology and providing information on the subject of scientific research in the field of biotechnology; scientific advisory services relating to gene therapy products and clinical trials, conducting clinical trials;.

Its status is currently believed to be active. Its class is unavailable. “TRIST” is believed to be currently owned by “Oxford BioMedica plc”.